A61K 47/183
Amino acids
Official title: {Amino acids, e.g. glycine, EDTA or aspartame}
A61K47/183 (Amino acids) appears on 2,485 US grants and 4,762 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,485
- Published applications
- 4,762
- Assignees
- 1,886
- Inventors
- 8,269
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 4 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 3 | 0 |
| 1982 | 6 | 0 |
| 1983 | 6 | 0 |
| 1984 | 3 | 0 |
| 1985 | 5 | 0 |
| 1986 | 8 | 0 |
| 1987 | 8 | 0 |
| 1988 | 3 | 0 |
| 1989 | 12 | 0 |
| 1990 | 15 | 0 |
| 1991 | 16 | 0 |
| 1992 | 17 | 0 |
| 1993 | 13 | 0 |
| 1994 | 12 | 0 |
| 1995 | 14 | 0 |
| 1996 | 36 | 0 |
| 1997 | 55 | 0 |
| 1998 | 38 | 0 |
| 1999 | 44 | 0 |
| 2000 | 27 | 0 |
| 2001 | 35 | 23 |
| 2002 | 36 | 59 |
| 2003 | 36 | 74 |
| 2004 | 30 | 77 |
| 2005 | 19 | 66 |
| 2006 | 20 | 60 |
| 2007 | 30 | 71 |
| 2008 | 19 | 90 |
| 2009 | 17 | 86 |
| 2010 | 47 | 100 |
| 2011 | 44 | 88 |
| 2012 | 50 | 95 |
| 2013 | 54 | 110 |
| 2014 | 87 | 133 |
| 2015 | 70 | 164 |
| 2016 | 111 | 163 |
| 2017 | 107 | 226 |
| 2018 | 111 | 225 |
| 2019 | 115 | 306 |
| 2020 | 155 | 326 |
| 2021 | 141 | 363 |
| 2022 | 172 | 361 |
| 2023 | 156 | 397 |
| 2024 | 176 | 386 |
| 2025 | 186 | 377 |
| 2026 | 109 | 336 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Topical anaesthetic composition having improved vasoconstrictor stability6 Oct 2026US 12,751,946 B2Animal Ethics Pty Ltd
- Protease composition6 Oct 2026US 12,751,997 B2Anatara Lifesciences Limited
- Liquid formulation22 Sep 2026US 12,741,011 B2Hanmi Pharm. Co., Ltd.
- Pharmaceutical formulations22 Sep 2026US 12,741,013 B2Novo Nordisk A/S
- Pharmaceutical formulations22 Sep 2026US 12,741,014 B2Novo Nordisk A/S
- Cosmetic composition comprising an endolysin and an organic filler8 Oct 2026US 2026/0306385 A1L'oreal
- Sulfurized imidazoles in ophthalmic formulations8 Oct 2026US 2026/0306431 A1Geneiii Biotech Company Ltd.
- Sulfurized imidazoles in ophthalmic formulations8 Oct 2026US 2026/0306457 A1Geneiii Biotech Company Ltd.
- Pyridylaminoacetic acid compound and polyoxyethylene castor oil-containing pharmaceutical composition8 Oct 2026US 2026/0306472 A1Santen Pharmaceutical Co., Ltd.
- Antiviral infusion composition8 Oct 2026US 2026/0306518 A1
Most cited
By later US patents
- Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use354US 5,091,171 A1992
- Reduced-viscosity concentrated protein formulations250US 6,875,432 B2Genentech, Inc. · 2005
- Methods and compositions for pulmonary delivery of insulin246US 5,997,848 AInhale Therapeutic Systems · 1999
- Formulation of a reconstituted protein, and method and kit for the production thereof234US 5,580,856 A1996
- Personal safety mobile notification system229US 8,624,727 B2Saigh and Son, LLC · 2014